gliptin and glp-1 Mechanism of action for GIP, analogues DPP4 inhibitors in Mechanism of action of sitagliptin,

This method allows for the GLP-1 drug to be absorbed into the bloodstream gradually, providing sustained effects over the course of the day

Patients should be advised to report suspected side effects via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)

GLP-1 receptor agonists promote weight loss through reduced appetite, increased feelings of fullness, and delayed gastric emptying

In mice, HSD aggravated liver damage , evident by serum ALT and histological analysis

Studies published in January and July 2024 showed an increased risk of NAION for patients using these drugs, with individuals who took them for weight loss at an even higher risk